Examining the Role of New and Emerging Therapies for the Treatment of Atopic Dermatitis

Factors to Consider When Treating Atopic Dermatitis with JAK Inhibitors

Supported by an independent educational grant from Pfizer

Review case management skills in this case-based microlearning course featuring a patient with atopic dermatitis.

Learning Objectives
 
After completing this activity, participants will be able to:
  1. Review the management of biologic therapies in a patient with atopic dermatitis
  2. Summarize the efficacy, risks, and benefits of switching to JAK inhibitors in a patient with atopic dermatitis

Faculty

User: James Song
James Song
MD

Dr. Song is the director of clinical research at Frontier Dermatology Partners. He is also a clinical instructor at the University of Washington and Silver Falls Dermatology. He specializes in inflammatory skin diseases, including psoriasis, atopic dermatitis, and hidradenitis suppurativa. Dr. Song is a regular contributor to the dermatology literature and speaks across the country as a key opinion leader.

View Bio

Related Courses

All material on this website is protected by copyright. Copyright © LearnHealth Inc. 2024.
This website also contains material copyrighted by 3rd parties.
ABOUT
LEGAL
SUBSCRIBE
To Get Posts Directly In Your Inbox!